[{"address1": "16305\u201336th Avenue North", "address2": "Suite 100", "city": "Minneapolis", "state": "MN", "zip": "55446", "country": "United States", "phone": "763 392 0767", "website": "https://www.celcuity.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Mr. Brian F. Sullivan", "age": 61, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 478115, "exercisedValue": 0, "unexercisedValue": 4216582}, {"maxAge": 1, "name": "Dr. Lance G. Laing Ph.D.", "age": 61, "title": "Co-Founder, Chief Science Officer, VP, Secretary & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 389547, "exercisedValue": 0, "unexercisedValue": 1365964}, {"maxAge": 1, "name": "Ms. Vicky  Hahne", "age": 57, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 281588, "exercisedValue": 0, "unexercisedValue": 827986}, {"maxAge": 1, "name": "Dr. John R. MacDonald Dabt, Ph., Ph.D.", "age": 68, "title": "Senior Vice President of R&D", "yearBorn": 1955, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sheri  Smith", "title": "Acting Head of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Igor  Gorbatchevsky M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eldon C. Mayer III, M.B.A.", "age": 62, "title": "Chief Commercial Officer", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Charlotte  Moser M.B.A., M.D., M.Sc., Ph.D.", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 8, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 15.61, "open": 15.65, "dayLow": 15.43, "dayHigh": 15.94, "regularMarketPreviousClose": 15.61, "regularMarketOpen": 15.65, "regularMarketDayLow": 15.43, "regularMarketDayHigh": 15.94, "beta": 0.757, "forwardPE": -4.903125, "volume": 120927, "regularMarketVolume": 120927, "averageVolume": 381387, "averageVolume10days": 378480, "averageDailyVolume10Day": 378480, "bid": 15.63, "ask": 15.7, "bidSize": 100, "askSize": 100, "marketCap": 581003840, "fiftyTwoWeekLow": 8.389, "fiftyTwoWeekHigh": 22.188, "fiftyDayAverage": 17.034, "twoHundredDayAverage": 16.2252, "currency": "USD", "enterpriseValue": 391460704, "floatShares": 22282781, "sharesOutstanding": 37030200, "sharesShort": 2494937, "sharesShortPriorMonth": 2269011, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0674, "heldPercentInsiders": 0.13053, "heldPercentInstitutions": 0.79598, "shortRatio": 5.82, "shortPercentOfFloat": 0.077, "bookValue": 4.773, "priceToBook": 3.2872407, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -82587288, "trailingEps": -2.73, "forwardEps": -3.2, "pegRatio": -0.22, "enterpriseToEbitda": -4.59, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CELC", "underlyingSymbol": "CELC", "shortName": "Celcuity Inc.", "longName": "Celcuity Inc.", "firstTradeDateEpochUtc": 1505914200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "3823f702-835a-3171-9799-5e1fe94326a8", "gmtOffSetMilliseconds": -14400000, "currentPrice": 15.69, "targetHighPrice": 39.0, "targetLowPrice": 23.0, "targetMeanPrice": 28.57, "targetMedianPrice": 27.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 283068416, "totalCashPerShare": 7.645, "ebitda": -85282056, "totalDebt": 96510288, "quickRatio": 14.495, "currentRatio": 14.949, "debtToEquity": 54.623, "returnOnAssets": -0.23933001, "returnOnEquity": -0.57589, "freeCashflow": -41856740, "operatingCashflow": -66417424, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]